Downregulation of the lncRNA PGM5P4-AS1 predicts poor prognosis and drives breast cancer progression through miR-3664-5p/KLF9
This study first shows that decreased PGM5P4-AS1 in BRCA patients links to poor prognosis, promotes malignancy via miR-3664-5p/KLF9 axis, offering new therapy and prognosis in sight.
Authors
- Yibo Huang
- Xiang Huang (ORCID: https://orcid.org/0000-0001-6028-3864)
- Yu Wu (ORCID: https://orcid.org/0000-0001-9596-5785)
- H Wang
- J. Jin
- Yuhan Zhang
- Hui Xie
Institutions
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Cancer Biology & Therapy
- Published
- 2025-12-27
- DOI
- https://doi.org/10.1080/15384047.2025.2606474
- Citations
- 1
- Primary Topic
- Kruppel-like factors research
- Type
- article
- Field-Weighted Citation Impact
- 0.81